
Global Glucagon Market By Type (Inject Glucagon, Nasal Glucagon), By Application (Emergency Kits, General Use, Diagnostic & Motility, Cardiogenic Shock and Others) and By Regions - Global Forecast 2030
15265
April 2023
234
“Global Glucagon Market” is the title of a recently published market report compiled by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global glucagon market has been segmented on the basis of type, application, as well as regions and countries.
The Global Glucagon Market was valued at UЅD $487.6 Мn in 2020, and is projected to achieve a valuation of UЅD $837 Мn by 2030, at a САGR of 6.6%.
Overview:
Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It works to raise the concentration of glucose and fatty acids in the bloodstream, and is considered to be the primary catabolic hormone of the body.
Dynamics:
Numerous advancements in the administration of non-injectable emergency glucagon, as well as the steady increase in the prevalence of hypoglycemia among individuals suffering from diabetes are some of the primary factors that are expected to continue to fuel the revenue growth of the global glucagon market over the next 10 years. Moreover, the increase in approvals for new products by respective governing bodies, and the steady elevation of awareness levels concerning the uses and benefits of this product are also factors that are slated to influence market growth for this global industry in the coming years.
Additionally, the steady expansion of geriatric populations across the world is another major factor that is expected to continue to boost revenue growth opportunities for the global glucagon market in the foreseeable future, as these individuals are more susceptible to developing chronic diseases and other disorders that would require the aid of products from this industry.
However, in light of the recent COVID-19 outbreak, the operations of numerous industries have either been temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global glucagon market is no different, and this factor is anticipated to have a negative impact on the revenue growth of this industry. Furthermore, the high cost of glucagon is another factor that may impede on the market growth of this global industry.
Nonetheless, numerous initiatives and increasing investments are being focused by key industry players towards the development of improved forms of treatment, as well as to make diabetes-related expenditures more economical, are some of the other factors that are expected to further augment future market growth for the global glucagon industry.
Segmentation of the Global Glucagon Market is as follows:
In terms of product type, the kits segment accounted for the maximum number of revenue shares of the global glucagon market in 2020, and is expected to index a high CAGR over the forecast period. However, the powder/solution segment is anticipated to index the highest CAGR over the next 10 years.
With regards to application, the emergency use segment accounted for the highest number of revenue shares of the global glucagon market in 2020, and is anticipated to continue doing so over the next decade. The general use segment is also indicative of registering a high CAGR over the forecast period.
Regional Segmentation and Analysis:
North America accounted for the maximum number of revenue shares of the global glucagon market in 2020, and is indicative of remaining this industry’s front-runner over the next decade. However, the markets in the Asia pacific region are anticipated to index the highest CAGR over the course of the forecast period.
Segmentation of the Global Glucagon Market:
Segmentation by Type:
- Inject Glucagon
- Nasal Glucagon
Segmentation by Application:
- Emergency Kits
- General Use
- Diagnostic & Motility
- Cardiogenic Shock
- Others
Segmentation by Regions:
- North America
- Europe
- APAC
- Latin America
- MEA
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn - Novo Nordisk A/S
- Eli Lilly & Co.
- Fresenius SE & Co. KGaA
- Torrent Pharmaceuticals Ltd.
- Xeris Pharmaceuticals, Inc.
- Svar Life Science AB
- Taj Pharmaceuticals Ltd
- Chapter 1 Global Glucagon Market Overview
- 1.1 Introduction
- 1.2 Segmentation for Global Glucagon Market, based on Type, Application, and Region
- 1.3 Drivers for Global Glucagon Market
- 1.4 Restraints for Global Glucagon Market
- 1.5 Opportunities for Global Glucagon Market
- 1.6 Trends for Global Glucagon Market
- 1.7 Macro-economic Factors
- 1.8 Opportunity Map Analysis
- 1.8.1 Optimistic Scenario
- 1.8.2 Likely Scenario
- 1.8.3 Conservative Scenario
- 1.9 Opportunity Orbits
- 1.10 Regional Market Share and BPS Analysis
- 1.11 Market Investment Feasibility Index
- 1.12 PEST Analysis
- 1.13 PORTER’S Five Force Analysis
- 1.14 Industry Chain Analysis
- 1.15 Cost Structure Analysis
- 1.16 Global Glucagon Market Downstream Buyer Analysis
- 1.17 Raw Material Suppliers List
- Chapter 2 Global Glucagon Market Overview
- 2.1 Global Glucagon Market by Application
- 2.1.1 Global Glucagon Revenue (US$ Mn) Comparison by Application (2013-2029)
- 2.1.2 Global Glucagon Revenue (US$ Mn) Market Share by Application in 2019
- 2.1.3 Global Glucagon Market Attractiveness Analysis by Application, 2013–2029
- 2.2 Global Glucagon Market by Product Type
- 2.2.1 Global Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2029)
- 2.2.2 Global Glucagon Revenue (US$ Mn) Market Share by Product Type in 2019
- 2.2.3 Global Glucagon Market Attractiveness Analysis by Product Type, 2013–2029
- 2.3 Global Glucagon Market Outlook by Region
- 2.3.1 Global Glucagon Revenue (US$ Mn) Comparison by Region (2013-2029)
- 2.3.2 Global Glucagon Revenue (US$ Mn) Market Share by Region in 2019
- 2.3.3 Global Glucagon Market Attractiveness Analysis by Region, 2013–2029
- 2.4 Global Glucagon Market Outlook (2013-2029)
- 2.4.1 Global Glucagon Revenue (US$ Mn) (2013-2020)
- 2.4.2 Global Glucagon Revenue (US$ Mn) (2021-2029)
- 2.5 Global Glucagon Revenue (US$ Mn) by Regions
- 2.5.1 Global Glucagon Revenue (US$ Mn) Comparison by Region (2013-2020)
- 2.5.2 Global Glucagon Revenue (US$ Mn) Comparison by Region (2021-2029)
- 2.6 Global Glucagon Revenue (US$ Mn) by Application
- 2.6.1 Global Glucagon Revenue (US$ Mn) Comparison by Application (2013-2020)
- 2.6.2 Global Glucagon Revenue (US$ Mn) Comparison by Application (2021-2029)
- 2.7 Global Glucagon Revenue (US$ Mn) by Product Type
- 2.7.1 Global Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2020)
- 2.7.2 Global Glucagon Revenue (US$ Mn) Comparison by Product Type (2021-2029)
- 2.8 Global Glucagon Y-o-Y Growth Rate Comparison 2014–2029
- 2.8.1 Global Glucagon Y-o-Y Growth Rate by Region
- 2.8.2 Global Glucagon Market Y-o-Y Growth Rate by Application
- 2.8.3 Global Glucagon Y-o-Y Growth Rate by Product Type
- 2.9 Global Glucagon Share Comparison 2014–2029
- 2.9.1 Global Glucagon Share by Region
- 2.9.2 Global Glucagon Market Share by Application
- 2.9.3 Global Glucagon Share by Product Type
- 2.1 Global Glucagon Market by Application
- Chapter 3 North America Glucagon Market Overview
- 3.1 North America Glucagon Market by Application
- 3.1.1 North America Glucagon Revenue (US$ Mn) Comparison by Application (2013-2029)
- 3.1.2 North America Glucagon Revenue (US$ Mn) Market Share by Application in 2019
- 3.1.3 North America Glucagon Market Attractiveness Analysis by Application, 2013–2029
- 3.2 North America Glucagon Market by Product Type
- 3.2.1 North America Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2029)
- 3.2.2 North America Glucagon Revenue (US$ Mn) Market Share by Product Type in 2019
- 3.2.3 North America Glucagon Market Attractiveness Analysis by Product Type, 2013–2029
- 3.3 North America Glucagon Market Outlook by Region
- 3.3.1 North America Glucagon Revenue (US$ Mn) Comparison by Region (2013-2029)
- 3.3.2 North America Glucagon Revenue (US$ Mn) Market Share by Region in 2019
- 3.3.3 North America Glucagon Market Attractiveness Analysis by Region, 2013–2029
- 3.4 North America Glucagon Market Outlook (2013-2029)
- 3.4.1 North America Glucagon Revenue (US$ Mn) (2013-2020)
- 3.4.2 North America Glucagon Revenue (US$ Mn) (2021-2029)
- 3.5 North America Glucagon Revenue (US$ Mn) by Regions
- 3.5.1 North America Glucagon Revenue (US$ Mn) Comparison by Region (2013-2020)
- 3.5.2 North America Glucagon Revenue (US$ Mn) Comparison by Region (2021-2029)
- 3.6 North America Glucagon Revenue (US$ Mn) by Application
- 3.6.1 North America Glucagon Revenue (US$ Mn) Comparison by Application (2013-2020)
- 3.6.2 North America Glucagon Revenue (US$ Mn) Comparison by Application (2021-2029)
- 3.7 North America Glucagon Revenue (US$ Mn) by Product Type
- 3.7.1 North America Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2020)
- 3.7.2 North America Glucagon Revenue (US$ Mn) Comparison by Product Type (2021-2029)
- 3.8 North America Glucagon Y-o-Y Growth Rate Comparison 2014–2029
- 3.8.1 North America Glucagon Y-o-Y Growth Rate by Region
- 3.8.2 North America Glucagon Market Y-o-Y Growth Rate by Application
- 3.8.3 North America Glucagon Y-o-Y Growth Rate by Product Type
- 3.9 North America Glucagon Share Comparison 2014–2029
- 3.9.1 North America Glucagon Share by Region
- 3.9.2 North America Glucagon Market Share by Application
- 3.9.3 North America Glucagon Share by Product Type
- 3.1 North America Glucagon Market by Application
- Chapter 4 Europe Glucagon Market Overview
- 4.1 Europe Glucagon Market by Application
- 4.1.1 Europe Glucagon Revenue (US$ Mn) Comparison by Application (2013-2029)
- 4.1.2 Europe Glucagon Revenue (US$ Mn) Market Share by Application in 2019
- 4.1.3 Europe Glucagon Market Attractiveness Analysis by Application, 2013–2029
- 4.2 Europe Glucagon Market by Product Type
- 4.2.1 Europe Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2029)
- 4.2.2 Europe Glucagon Revenue (US$ Mn) Market Share by Product Type in 2019
- 4.2.3 Europe Glucagon Market Attractiveness Analysis by Product Type, 2013–2029
- 4.3 Europe Glucagon Market Outlook by Region
- 4.3.1 Europe Glucagon Revenue (US$ Mn) Comparison by Region (2013-2029)
- 4.3.2 Europe Glucagon Revenue (US$ Mn) Market Share by Region in 2019
- 4.3.3 Europe Glucagon Market Attractiveness Analysis by Region, 2013–2029
- 4.4 Europe Glucagon Market Outlook (2013-2029)
- 4.4.1 Europe Glucagon Revenue (US$ Mn) (2013-2020)
- 4.4.2 Europe Glucagon Revenue (US$ Mn) (2021-2029)
- 4.5 Europe Glucagon Revenue (US$ Mn) by Regions
- 4.5.1 Europe Glucagon Revenue (US$ Mn) Comparison by Region (2013-2020)
- 4.5.2 Europe Glucagon Revenue (US$ Mn) Comparison by Region (2021-2029)
- 4.6 Europe Glucagon Revenue (US$ Mn) by Application
- 4.6.1 Europe Glucagon Revenue (US$ Mn) Comparison by Application (2013-2020)
- 4.6.2 Europe Glucagon Revenue (US$ Mn) Comparison by Application (2021-2029)
- 4.7 Europe Glucagon Revenue (US$ Mn) by Product Type
- 4.7.1 Europe Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2020)
- 4.7.2 Europe Glucagon Revenue (US$ Mn) Comparison by Product Type (2021-2029)
- 4.8 Europe Glucagon Y-o-Y Growth Rate Comparison 2014–2029
- 4.8.1 Europe Glucagon Y-o-Y Growth Rate by Region
- 4.8.2 Europe Glucagon Market Y-o-Y Growth Rate by Application
- 4.8.3 Europe Glucagon Y-o-Y Growth Rate by Product Type
- 4.9 Europe Glucagon Share Comparison 2014–2029
- 4.9.1 Europe Glucagon Share by Region
- 4.9.2 Europe Glucagon Market Share by Application
- 4.9.3 Europe Glucagon Share by Product Type
- 4.1 Europe Glucagon Market by Application
- Chapter 5 APAC Glucagon Market Overview
- 5.1 APAC Glucagon Market by Application
- 5.1.1 APAC Glucagon Revenue (US$ Mn) Comparison by Application (2013-2029)
- 5.1.2 APAC Glucagon Revenue (US$ Mn) Market Share by Application in 2019
- 5.1.3 APAC Glucagon Market Attractiveness Analysis by Application, 2013–2029
- 5.2 APAC Glucagon Market by Product Type
- 5.2.1 APAC Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2029)
- 5.2.2 APAC Glucagon Revenue (US$ Mn) Market Share by Product Type in 2019
- 5.2.3 APAC Glucagon Market Attractiveness Analysis by Product Type, 2013–2029
- 5.3 APAC Glucagon Market Outlook by Region
- 5.3.1 APAC Glucagon Revenue (US$ Mn) Comparison by Region (2013-2029)
- 5.3.2 APAC Glucagon Revenue (US$ Mn) Market Share by Region in 2019
- 5.3.3 APAC Glucagon Market Attractiveness Analysis by Region, 2013–2029
- 5.4 APAC Glucagon Market Outlook (2013-2029)
- 5.4.1 APAC Glucagon Revenue (US$ Mn) (2013-2020)
- 5.4.2 APAC Glucagon Revenue (US$ Mn) (2021-2029)
- 5.5 APAC Glucagon Revenue (US$ Mn) by Regions
- 5.5.1 APAC Glucagon Revenue (US$ Mn) Comparison by Region (2013-2020)
- 5.5.2 APAC Glucagon Revenue (US$ Mn) Comparison by Region (2021-2029)
- 5.6 APAC Glucagon Revenue (US$ Mn) by Application
- 5.6.1 APAC Glucagon Revenue (US$ Mn) Comparison by Application (2013-2020)
- 5.6.2 APAC Glucagon Revenue (US$ Mn) Comparison by Application (2021-2029)
- 5.7 APAC Glucagon Revenue (US$ Mn) by Product Type
- 5.7.1 APAC Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2020)
- 5.7.2 APAC Glucagon Revenue (US$ Mn) Comparison by Product Type (2021-2029)
- 5.8 APAC Glucagon Y-o-Y Growth Rate Comparison 2014–2029
- 5.8.1 APAC Glucagon Y-o-Y Growth Rate by Region
- 5.8.2 APAC Glucagon Market Y-o-Y Growth Rate by Application
- 5.8.3 APAC Glucagon Y-o-Y Growth Rate by Product Type
- 5.9 APAC Glucagon Share Comparison 2014–2029
- 5.9.1 APAC Glucagon Share by Region
- 5.9.2 APAC Glucagon Market Share by Application
- 5.9.3 APAC Glucagon Share by Product Type
- 5.1 APAC Glucagon Market by Application
- Chapter 6 South America Glucagon Market Overview
- 6.1 South America Glucagon Market by Application
- 6.1.1 South America Glucagon Revenue (US$ Mn) Comparison by Application (2013-2029)
- 6.1.2 South America Glucagon Revenue (US$ Mn) Market Share by Application in 2019
- 6.1.3 South America Glucagon Market Attractiveness Analysis by Application, 2013–2029
- 6.2 South America Glucagon Market by Product Type
- 6.2.1 South America Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2029)
- 6.2.2 South America Glucagon Revenue (US$ Mn) Market Share by Product Type in 2019
- 6.2.3 South America Glucagon Market Attractiveness Analysis by Product Type, 2013–2029
- 6.3 South America Glucagon Market Outlook by Region
- 6.3.1 South America Glucagon Revenue (US$ Mn) Comparison by Region (2013-2029)
- 6.3.2 South America Glucagon Revenue (US$ Mn) Market Share by Region in 2019
- 6.3.3 South America Glucagon Market Attractiveness Analysis by Region, 2013–2029
- 6.4 South America Glucagon Market Outlook (2013-2029)
- 6.4.1 South America Glucagon Revenue (US$ Mn) (2013-2020)
- 6.4.2 South America Glucagon Revenue (US$ Mn) (2021-2029)
- 6.5 South America Glucagon Revenue (US$ Mn) by Regions
- 6.5.1 South America Glucagon Revenue (US$ Mn) Comparison by Region (2013-2020)
- 6.5.2 South America Glucagon Revenue (US$ Mn) Comparison by Region (2021-2029)
- 6.6 South America Glucagon Revenue (US$ Mn) by Application
- 6.6.1 South America Glucagon Revenue (US$ Mn) Comparison by Application (2013-2020)
- 6.6.2 South America Glucagon Revenue (US$ Mn) Comparison by Application (2021-2029)
- 6.7 South America Glucagon Revenue (US$ Mn) by Product Type
- 6.7.1 South America Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2020)
- 6.7.2 South America Glucagon Revenue (US$ Mn) Comparison by Product Type (2021-2029)
- 6.8 South America Glucagon Y-o-Y Growth Rate Comparison 2014–2029
- 6.8.1 South America Glucagon Y-o-Y Growth Rate by Region
- 6.8.2 South America Glucagon Market Y-o-Y Growth Rate by Application
- 6.8.3 South America Glucagon Y-o-Y Growth Rate by Product Type
- 6.9 South America Glucagon Share Comparison 2014–2029
- 6.9.1 South America Glucagon Share by Region
- 6.9.2 South America Glucagon Market Share by Application
- 6.9.3 South America Glucagon Share by Product Type
- 6.1 South America Glucagon Market by Application
- Chapter 7 MEA Glucagon Market Overview
- 7.1 MEA Glucagon Market by Application
- 7.1.1 MEA Glucagon Revenue (US$ Mn) Comparison by Application (2013-2029)
- 7.1.2 MEA Glucagon Revenue (US$ Mn) Market Share by Application in 2019
- 7.1.3 MEA Glucagon Market Attractiveness Analysis by Application, 2013–2029
- 7.2 MEA Glucagon Market by Product Type
- 7.2.1 MEA Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2029)
- 7.2.2 MEA Glucagon Revenue (US$ Mn) Market Share by Product Type in 2019
- 7.2.3 MEA Glucagon Market Attractiveness Analysis by Product Type, 2013–2029
- 7.3 MEA Glucagon Market Outlook by Region
- 7.3.1 MEA Glucagon Revenue (US$ Mn) Comparison by Region (2013-2029)
- 7.3.2 MEA Glucagon Revenue (US$ Mn) Market Share by Region in 2019
- 7.3.3 MEA Glucagon Market Attractiveness Analysis by Region, 2013–2029
- 7.4 MEA Glucagon Market Outlook (2013-2029)
- 7.4.1 MEA Glucagon Revenue (US$ Mn) (2013-2020)
- 7.4.2 MEA Glucagon Revenue (US$ Mn) (2021-2029)
- 7.5 MEA Glucagon Revenue (US$ Mn) by Regions
- 7.5.1 MEA Glucagon Revenue (US$ Mn) Comparison by Region (2013-2020)
- 7.5.2 MEA Glucagon Revenue (US$ Mn) Comparison by Region (2021-2029)
- 7.6 MEA Glucagon Revenue (US$ Mn) by Application
- 7.6.1 MEA Glucagon Revenue (US$ Mn) Comparison by Application (2013-2020)
- 7.6.2 MEA Glucagon Revenue (US$ Mn) Comparison by Application (2021-2029)
- 7.7 MEA Glucagon Revenue (US$ Mn) by Product Type
- 7.7.1 MEA Glucagon Revenue (US$ Mn) Comparison by Product Type (2013-2020)
- 7.7.2 MEA Glucagon Revenue (US$ Mn) Comparison by Product Type (2021-2029)
- 7.8 MEA Glucagon Y-o-Y Growth Rate Comparison 2014–2029
- 7.8.1 MEA Glucagon Y-o-Y Growth Rate by Region
- 7.8.2 MEA Glucagon Market Y-o-Y Growth Rate by Application
- 7.8.3 MEA Glucagon Y-o-Y Growth Rate by Product Type
- 7.9 MEA Glucagon Share Comparison 2014–2029
- 7.9.1 MEA Glucagon Share by Region
- 7.9.2 MEA Glucagon Market Share by Application
- 7.9.3 MEA Glucagon Share by Product Type
- 7.1 MEA Glucagon Market by Application
- Chapter 8 Global Glucagon Market Company Profile
- 8.1 Market Competition Scenario Analysis
- 8.2 Overview of Major Market Players
- 8.3 Company Profiles
- 8.3.1 Novo Nordisk A/S
- 8.3.1.1 Company Overview
- 8.3.1.2 Business Description
- 8.3.1.3 Product Portfolio
- 8.3.1.4 Key Financials
- 8.3.1.5 Key Developments
- 8.3.1.6 SWOT Analysis
- 8.3.2 Eli Lilly & Co.
- 8.3.2.1 Company Overview
- 8.3.2.2 Business Description
- 8.3.2.3 Product Portfolio
- 8.3.2.4 Key Financials
- 8.3.2.5 Key Developments
- 8.3.2.6 SWOT Analysis
- 8.3.3 Fresenius SE & Co. KGaA
- 8.3.3.1 Company Overview
- 8.3.3.2 Business Description
- 8.3.3.3 Product Portfolio
- 8.3.3.4 Key Financials
- 8.3.3.5 Key Developments
- 8.3.3.6 SWOT Analysis
- 8.3.4 Torrent Pharmaceuticals Ltd.
- 8.3.4.1 Company Overview
- 8.3.4.2 Business Description
- 8.3.4.3 Product Portfolio
- 8.3.4.4 Key Financials
- 8.3.4.5 Key Developments
- 8.3.5 Xeris Pharmaceuticals, Inc.
- 8.3.5.1 Company Overview
- 8.3.5.2 Business Description
- 8.3.5.3 Product Portfolio
- 8.3.5.4 Key Financials
- 8.3.6 Svar Life Science AB
- 8.3.6.1 Company Overview
- 8.3.6.2 Business Description
- 8.3.6.3 Product Portfolio
- 8.3.6.4 Key Developments
- 8.3.7 Taj Pharmaceuticals Ltd.
- 8.3.7.1 Company Overview
- 8.3.7.2 Business Description
- 8.3.7.3 Product Portfolio
- 8.3.1 Novo Nordisk A/S
- Chapter 9 Research Methodology
- 9.1 Research Methodology
- 9.2 Primary Research
- 9.3 Secondary Research
- 9.4 Report Scope
- Chapter 10 About Us
- 10.1 Who we are
- Chapter 1 Global Glucagon Market Overview
Inquiry Form
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Frequently Asked Questions (FAQ)
Revenue from the kits segment in the global glucagon market is projected to register a CAGR of 6.3% during the forecast period.
Revenue from the global glucagon market is projected to register a CAGR of 6.2 % during the forecast period
The projected revenue share of the global glucagon market in 2029 is US$ 837.0 Mn.
Revenue from the global glucagon market is expected to reach US$ 837.0 Mn over the forecast period
In 2022, the emergency use segment is projected to account for highest revenue of US$ 416.5 Mn
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!